Second-Gen Sequencers Can Perform Targeted Sequencing But Could Improve, Study Finds

The researchers found that now-outdated versions of the Roche/454, Illumina, and Life Technologies systems each suffered from non-uniform coverage and inherent systematic errors, making it difficult to use data from different platforms for the same study.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.